PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Recruiting

Phase 1

Phase 2

PBGENE-DMDPBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Sponsor:

Precision BioSciences, Inc.

Code:

NCT07429240

Conditions

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD

Eligibility Criteria

Sex: Male

Age: 2 - 7

Healthy Volunteers: Not accepted

Interventions

PBGENE-DMD (IV)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-16. This information was provided to ClinicalTrials.gov by Precision BioSciences, Inc. on 2026-04-30.